Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiovascular Systems Inc (NASDAQ:CSII)

During the Trading Day
13.62 -3.01 / -18.10%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.62 0.00 / 0.00%
Volume: 10.6K
Health Technology
Medical Specialties

Company Description

Cardiovascular Systems, Inc. is a medial device company that develops and sells devices for treating cardiovascular diseases. It focuses on developing and commercializing minimally invasive treatment solutions for vascular diseases. The company's products such as diamondback 360° PAD system and the stealth 360° PAD system are catheter based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee. It was formerly known as Replidyne, Inc. Cardiovascular Systems was founded in 2000 and is headquartered in St. Paul, MN.

Contact Information

Cardiovascular Systems, Inc.
651 Campus Drive
St. Paul Minnesota 55112-3495
P:(651) 259-1600
Investor Relations:



Other institutional36.78%
Mutual fund holders36.76%
Individual stakeholders21.03%

Top Executives

David L. MartinPresident, Chief Executive Officer & Director
Kevin J. KennyChief Operating Officer
Laurence L. BetterleyChief Financial Officer
Michael X. YangVice President-Science & Research
James E. FlahertySecretary & Chief Administrative Officer